ArticleMolecular therapy. Nucleic acids2024

miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44.

Shang-Gin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.